Loading insider details...
Beta
Latest Form 4 (May 5, 2026): Grant/Award of 1,756,069 KTTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 5, 2026 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 1,756,069 | n/a |
| Dec 1, 2025 | Pasithea Therapeutics Corp. (KTTA) | Purchase | 33,333 | $25.0K |
| Oct 27, 2025 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 493,341 | n/a |
| May 15, 2025 | Pasithea Therapeutics Corp. (KTTA) | Sale | 960 | $792.00 |
| Mar 2, 2024 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 15,000 | n/a |
| Nov 28, 2022 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 5,000 | $5.0K |
| Oct 21, 2022 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 600 | $648.00 |
| Jun 23, 2022 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 2,900 | $2.9K |
| Dec 22, 2021 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 200,000 | n/a |